GlassScriptPhysician profile
Diana Crook
NPI 1679530760
$10,661.93
in general payments reported to CMS, 2019-2025
46 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,758 · 2020: $1,659 · 2021: $2,143 · 2022: $933 · 2023: $1,483 · 2024: $1,361 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,133 · Education: $35.13.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,133.48 |
| Education | $35.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,523.26 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $1,370.58 | 2019-2025 | Wegovy |
| Amgen INC. | $1,203.93 | 2019-2024 | Evenity, Repatha |
| Abbvie INC. | $785.76 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $591.51 | 2019-2025 | Spravato, Xarelto |
| Lilly USA, LLC | $525.05 | 2019-2023 | Mounjaro |
| Glaxosmithkline, LLC. | $472.39 | 2020-2025 | Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $435.11 | 2019-2024 | |
| Paratek Pharmaceuticals, INC. | $374.97 | 2023-2025 | Nuzyra |
| Biohaven Pharmaceuticals, INC. | $299.00 | 2021 | |
| Phathom Pharmaceuticals, INC. | $229.65 | 2024 | Voquezna |
| Urovant Sciences INC | $201.43 | 2021-2022 | |
| Pfizer INC. | $186.20 | 2019-2025 | |
| Exact Sciences Corporation | $174.09 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Astellas Pharma US INC | $165.01 | 2019 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diana Crook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.